Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Angiodynamics (ANGO) Accumulated Depreciation & Amortization (2016 - 2025)

Angiodynamics' Accumulated Depreciation & Amortization history spans 15 years, with the latest figure at -$31.9 million for Q2 2025.

  • For Q2 2025, Accumulated Depreciation & Amortization rose 3.39% year-over-year to -$31.9 million; the TTM value through May 2025 reached -$31.9 million, up 3.39%, while the annual FY2025 figure was -$31.9 million, 3.39% up from the prior year.
  • Accumulated Depreciation & Amortization reached -$31.9 million in Q2 2025 per ANGO's latest filing, up from -$33.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $58.5 million in Q2 2023 to a low of -$33.0 million in Q2 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $17.9 million, with a median of $45.2 million recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 15.73% in 2023, then plummeted 156.43% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $45.2 million in 2021, then increased by 11.99% to $50.6 million in 2022, then grew by 15.73% to $58.5 million in 2023, then plummeted by 156.43% to -$33.0 million in 2024, then grew by 3.39% to -$31.9 million in 2025.
  • Per Business Quant, the three most recent readings for ANGO's Accumulated Depreciation & Amortization are -$31.9 million (Q2 2025), -$33.0 million (Q2 2024), and $58.5 million (Q2 2023).